杭氧股份所属申万行业为：基础化工-化学制品-其他化学制品。所属概念板块包括：中盘、融资融券、 芯片概念、一带一路、国资改革等。 截至8月10日，杭氧股份股东户数2.99万，较上期增加1.89%；人均流通股32697股，较上期减少1.86%。 2025年1月-6月，杭氧股份实现营业收入73.27亿元，同比增长8.92%；归母净利润4.79亿元，同比增长 9.61%。 9月8日，杭氧股份盘中上涨2.00%，截至10:08，报23.97元/股，成交1.05亿元，换手率0.45%，总市值 234.51亿元。 资金流向方面，主力资金净流出490.86万元，特大单买入1468.85万元，占比14.01%，卖出2030.88万 元，占比19.37%；大单买入2163.16万元，占比20.63%，卖出2091.99万元，占比19.95%。 杭氧股份今年以来股价涨11.49%，近5个交易日跌0.54%，近20日涨5.69%，近60日涨24.78%。 资料显示，杭氧集团股份有限公司位于浙江省杭州市临安区青山湖街道相府路799号，成立日期2002年 12月18日，上市日期2010年6月10日，公司主营业务涉及空气分离设备、工业气体 ...

杭氧股份 20250902 杭氧股份在核聚变领域的布局情况和进展如何？ 杭氧股份凭借其在低温技术领域的优势，正在积极布局核聚变领域。公司主要 从事空分设备和工业气体业务，深低温技术是其核心竞争力之一。目前，公司 在低温技术应用方面已经取得了显著成效，营业收入达到 130 多亿元，并成为 全球最大的通风设备制造商。随着中国经济的快速增长和产业结构转型升级， 低温技术在新兴战略产业中有了更多应用机会。杭氧股份看好可控核聚变方向， 并认为短期内会有一些成果。在核聚变装置的低温系统中，公司可以提供膨胀 机、压缩机、泵阀、储罐等核心装备，以及氦液化系统、氮制冷剂系统等子系 可控核聚变制冷剂技术与传统空分设备的核心区别在于介质和温度，前 者使用氦气，工作温度极低（2K-4.5K），技术难度更高。杭氧股份已 具备相关技术基础，转型相对容易，是对已有主业的延伸和定制化应用。 杭氧股份在 2025 年 5 月至 6 月迅速组建了专门针对可控核聚变项目的 小组，由常务副总经理领导，整合高端装备事业部、气体应用研究院等 资源，与合肥和成都的下游客户保持顺畅沟通，进行技术对接。 杭氧股份工厂已开始生产应用于核聚变领域的样机，积极对接 ...

| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 300530 | 领湃科技 | 40.53 | 12.30% | 24.81万 | | 9.92亿 | | 603051 | 鹿山新材 | 23.28 | 10.02% | 11.26万 | | 2.58亿 | | 603823 | 百合花 | 16.08 | 6.63% | 32.78万 | | 5.13亿 | | 002915 | 中欣氟材 | 28.92 | 6.32% | 66.28万 | | 18.47亿 | | 688196 | 卓越新能 | 49.29 | 6.00% | 3.06万 | | 1.50亿 | | 002211 | ST宏达 | 3.59 | 4.97% | 18.10万 | | 6301.12万 | | 301076 | 新潮新材 | 54.60 | 3.74% | 30.16万 | | 15.73亿 | | 830974 | 凯大催化 | 9.65 | 3.43% | 13.28万 | | 1.28亿 ...

股票代码：002430 股票简称：杭氧股份 公告编号：2025-085 转债代码：127064 转债简称：杭氧转债 杭氧集团股份有限公司 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误 导性陈述或重大遗漏。 特别提示： 理完成 5,539,375 股限制性股票的回购注销手续，回购注销数量占回购注销前公司总 股本的 0.5630%。 杭氧集团股份有限公司董事会 二、增持计划实施情况 公司于 2025 年 8 月 29 日收到杭氧控股出具的《关于增持杭氧股票实施进展情 况暨增持股份触及 1%的告知函》。杭氧控股于 2025 年 4 月 10 日至 2025 年 8 月 29 日期间通过深圳证券交易所以集中竞价方式累计增持公司股份 3,778,286 股，占公司 总股本的 0.3862%。本次增持后，杭氧控股持有公司股份 528,532,771 股，占公司总 股本的 54.0228%，权益变动触及 1%的整数倍。本次增持计划尚未实施完毕，杭氧 控股将继续按照计划择机开展股份增持。 三、股东权益变动情况 | 信息披露义务人 | 杭州杭氧控股有限公司 | | | | | | | | | -- ...

| | | 股票代码：002430 股票简称：杭氧股份 公告编号：2025-085 转债代码：127064 转债简称：杭氧转债 杭氧集团股份有限公司 关于控股股东增持公司股份触及1%整数倍的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误 导性陈述或重大遗漏。 特别提示： 1、公司已于 2025 年 7 月 18 日在中国证券登记结算有限责任公司深圳分公司办 理完成 5,539,375 股限制性股票的回购注销手续，回购注销数量占回购注销前公司总 股本的 0.5630%。 2、截至 2025 年 8 月 29 日，公司总股本为 978,351,332 股。 一、增持计划基本情况 杭氧集团股份有限公司（以下简称"杭氧股份"或"公司"）于 2025 年 4 月 10 日披露了《关于控股股东增持公司股份计划的公告》（公告编号：2025-032），公司 控股股东杭州杭氧控股有限公司（以下简称"杭氧控股"）基于对公司长期投资价 值的认可及未来发展前景信心，计划自 2025 年 4 月 10 日起 6 个月内，通过二级市 场增持公司股份，包括集中竞价、大宗交易等方式，增持金额不低于人民币 1 ...

Core Viewpoint - Hangyang Co., Ltd. has experienced fluctuations in stock price and trading volume, with a notable increase in revenue and net profit year-on-year for the first half of 2025 [1][2]. Group 1: Stock Performance - As of September 1, Hangyang's stock price decreased by 2.04%, trading at 24.03 CNY per share, with a total market capitalization of 23.51 billion CNY [1]. - Year-to-date, Hangyang's stock price has increased by 11.77%, with a 0.33% rise over the last five trading days, 7.56% over the last 20 days, and 24.06% over the last 60 days [2]. Group 2: Financial Performance - For the period from January to June 2025, Hangyang achieved a revenue of 7.33 billion CNY, representing a year-on-year growth of 8.92%, and a net profit attributable to shareholders of 479 million CNY, up by 9.61% [2]. - Since its A-share listing, Hangyang has distributed a total of 3.72 billion CNY in dividends, with 2.07 billion CNY distributed over the past three years [3]. Group 3: Shareholder and Institutional Holdings - As of June 30, 2025, the number of shareholders for Hangyang was 29,900, an increase of 1.89% from the previous period, with an average of 32,697 circulating shares per shareholder, a decrease of 1.86% [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 28.21 million shares, a decrease of 12.42 million shares from the previous period [3].

从估值方面来看，Wind数据显示，截至上个交易日（8月29日）收盘，化工ETF（516020）标的指数细 分化工指数市净率为2.26倍，位于近10年来36.86%分位点的低位，中长期配置性价比凸显。 东方证券指出，随着各方面关于"反内卷"政策的解读逐渐丰富，市场对于政策的理解也不断深入。其认 为"反内卷"政策对于化工来说并不是简单的"去产能"，而是通过规范政策、市场、企业经营等方面来消 除不公平竞争导致的内卷。"反内卷"政策作为制造业当前最重要的指引性政策之一，各子行业都会展开 行动，后续有望持续出台更多针对行业痛点的政策，引领当前现状较差的化工行业走出景气谷底。 展望后市，国海证券表示，反内卷有望重估中国化工行业后续措施有望使全球化工行业产能扩张大幅放 缓。中国化工行业具有充沛的经营活动现金流量净额，一旦扩张放缓，潜在股息率将大幅提升，有望实 现从吞金兽到摇钱树的转变；同时，供给端的改变将带来景气度的止跌回升，化工标的有望兼具高弹性 和高股息的优势。 如何把握化工板块反弹机遇？借道化工ETF（516020）布局效率或更高。公开资料显示，化工ETF （516020）跟踪中证细分化工产业主题指数，全面覆盖化工各 ...

Group 1 - The core viewpoint of the news is that Hangyang Co., Ltd. has shown significant trading activity and financial performance, with a notable increase in financing and stockholder numbers [1][2][3] - As of August 29, Hangyang's stock price decreased by 0.53%, with a trading volume of 306 million yuan and a net financing purchase of 26.89 million yuan [1] - The company's financing balance reached 460 million yuan, accounting for 1.89% of its market capitalization, indicating a high level of financing activity compared to the past year [1] Group 2 - For the first half of 2025, Hangyang reported a revenue of 7.327 billion yuan, representing a year-on-year growth of 8.92%, and a net profit attributable to shareholders of 479 million yuan, up 9.61% [2] - The company has distributed a total of 3.723 billion yuan in dividends since its A-share listing, with 2.067 billion yuan distributed in the last three years [3] - As of June 30, 2025, the top ten circulating shareholders included Hong Kong Central Clearing Limited, which reduced its holdings by 12.42 million shares [3]

丨证券研究报告丨 联合研究丨公司点评丨杭氧股份（002430.SZ） [Table_Title] 杭氧股份半年报点评：气体销售业务回暖，积极 开拓海外市场 报告要点 [Table_Summary] 杭氧股份发布 2025 年半年度报告，2025H1 实现营业收入 73.27 亿元，同比+8.92%，实现归 母净利润 4.79 亿元，同比+9.61%。其中 2025Q2 实现营业收入 37.63 亿元，同比+9.95%，实 现归母净利润 2.53 亿元，同比+8.55%。 [Table_Author] 赵智勇 魏凯 曹小敏 王岭峰 SAC：S0490517110001 SAC：S0490520080009 SAC：S0490521050001 SAC：S0490521080001 SFC：BRP550 SFC：BUT964 SFC：BWF918 请阅读最后评级说明和重要声明 %% %% 分析师及联系人 %% %% research.95579.com 1 杭氧股份（002430.SZ） cjzqdt11111 [Table_Title 杭氧股份半年报点评：气体销售业务回暖，积极 2] 开拓海外市场 [Table ...

Core Viewpoint - The company has shown steady growth in revenue and profit in the first half of 2025, with a notable increase in non-recurring net profit, driven by a recovery in gas prices and resilient equipment orders [1][3]. Financial Performance - In H1 2025, the company achieved operating revenue of 7.327 billion, a year-on-year increase of 8.92%, and a net profit attributable to shareholders of 479 million, up 9.61% year-on-year [1]. - For Q2 2025, the company reported operating revenue of 3.763 billion, a year-on-year increase of 10%, and a net profit attributable to shareholders of 253 million, up 8.55% year-on-year [1]. - The non-recurring net profit for H1 2025 was 461 million, reflecting a year-on-year growth of 13.40% [1]. Business Segments - The gas business experienced a "volume and price increase" trend, with revenue up 14% and gross margin up 2.8 percentage points, benefiting from rising prices of liquid oxygen and other gases [1]. - The equipment business showed relatively weak performance, with revenue growth of 4.2% but a decline in gross margin by 4.1 percentage points [1]. Market Trends - The price of liquid oxygen has shown signs of recovery, with an average price of 481 yuan/ton as of August 21, 2025, reflecting a year-on-year increase of 18.77% [2]. - The overseas demand for liquid oxygen surged, with exports totaling 6,821.53 tons in the first half of 2025, a year-on-year increase of 129% [2]. - The industrial gas market remains under pressure, with prices for liquid oxygen and nitrogen fluctuating at low levels, but there are expectations for marginal improvements in supply-demand dynamics due to the growth in high-value applications [2]. Equipment Business Expansion - The equipment business achieved record growth in H1 2025, signing significant orders including two sets of 120,000 cubic meter air separation units for a major project, marking a technological breakthrough in domestic large-scale equipment [3]. - The company made significant strides in overseas markets, including the first large air separation unit project in Africa and multiple orders in Europe and Southeast Asia [3]. Future Outlook - The company maintains a "strongly recommended" rating, anticipating stable growth in gas business and improved profitability from ongoing projects as depreciation costs decrease over the coming years [3]. - Projected net profits for 2025-2027 are estimated at 1.039 billion, 1.297 billion, and 1.409 billion respectively [3].